Abstract
Abstract
Li, Hongge, Songchang Guo, Yongming Ren, Depeng Wang, Honghao Yu, Wenjing Li, Xinquan Zhao, and Zhijie Chang. VEGF189 expression is highly related to adaptation of the plateau pika (Ochotona curzoniae) inhabiting high altitudes. High Alt Med Biol 14:395–404, 2013.— The plateau pika (Ochotona curzonia) has adapted to high-altitude hypoxia during evolution. Higher microvessel density in specific tissues and a blunted hypoxic pulmonary vasoconstriction response are the critical components of this adaptation. VEGF, vascular endothelial growth factor, has proved to be a key regulator of angiogenesis in response to tissue hypoxia and to play an important role in vascular vasodilation. However, the role of VEGF in adaptation to high-altitude hypoxia in the plateau pika remains unknown. In this study, we cloned cDNAs for VEGF165 and VEGF189 and examined their expression in pikas inhabiting altitudes of 3200 and 4750 m. Phylogenetic analysis reveals that pika VEGF165 and VEGF189 are evolutionarily conserved. Real-time PCR analysis demonstrates that VEGF165 and VEGF189 display tissue and altitude-specific expression patterns. Interestingly, we found that the levels of VEGF189 mRNA are significantly higher than those of VEGF165 in the brain and muscle tissues of the pika, which is different from what was previously observed in sea-level mammals. VEGF189 mRNA levels in brain, muscle, and lung of the pika increased with increased habitat altitude, whereas VEGF165 shows less change. Our study suggests an important role for VEGF189 in adaptation to hypoxia by the plateau pika in the high-altitude environment.
Introduction
H
The plateau pika (Ochotona cuzoniae) is a small, nonhibernating mammal that inhabits alpine meadows above 3000 m, and is a keystone species on the Qinghai–Tibetan plateau ecosystem (Fig. 1). Over the course of evolution, the plateau pika has acquired a remarkable tolerance to hypoxia and the cold plateau environment by improving the utilization of oxygen (Du et al., 1982), increasing the resting metabolic rate, and having a nonshivering thermogenesis (Li et al., 2001). A number of strategies that are used by the pika to adapt to the harsh environment have been elucidated. These strategies include: 1) an increase in erythrocyte count, reduction in the mean corpuscular volume (Ye et al., 1994), changes in hemoglobin (Hb) and 2,3-diphosphoglycerate concentrations (Ge et al., 1998), and an increase in the oxygen affinity to Hb (He et al., 1994); 2) adaptation to its environment in terms of hepatic function, metabolism (Li et al., 1986), and neuroendocrine function (Du et al., 1983, Wu et al., 2001); 3) blunted hypoxic pulmonary vasoconstriction and thin-walled pulmonary arterioles (Ge et al., 1998); and 4) higher capillary densities, mitochondrial density, and concentration of myoglobin (for heart) in heart and lung (Qi et al., 2008, Wang et al., 2008). All these strategies reveal that the pika's adaptation to high altitudes occurs at both the physiological and biochemical levels.

The plateau pika (Ochotona curzoniae), also known as the black-lipped pika, is a species of mammal in the Ochotonidae family commonly known as pika. They prefer to live in elevation of 3000 to 5000 m, mostly in the Tibetan Plateau.
The molecular basis of these adaptations in the pika have occurred because of evolutionary changes in several critical factors, including HIF-1α (Li et al., 2008, Zhao et al., 2004), leptin (Yang et al., 2006, 2008), and hemoglobin (Yingzhong et al., 2007). These factors have been reported to be expressed in a tissue-specific manner (Zhao et al., 2004) and with changes that are related to altitude (Li et al., 2008, Yang et al., 2006).
Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis, the formation of new capillaries from pre-existing vasculature, during development and in response to tissue hypoxia. In addition, VEGF has been reported to cause vasodilatation in vitro in a dose-dependent manner (Ku et al., 1993) and to have effects on hematopoiesis and bone marrow-derived cells (Broxmeyer et al., 1995, Gerber et al., 2002, Hattori et al., 2001). Furthermore, VEGF expression is tightly regulated at the levels of transcription, mRNA stability (Levy et al., 1998) and translation (Stein et al., 1998) under hypoxia. Hypoxia inducible factor 1 (HIF-1), a key mediator of the hypoxic response, induces transcription of VEGF (Forsythe et al., 1996).
VEGF is expressed as several different isoforms due to alternative splicing of the primary transcript depending on the presence or absence of exons 6 and 7 (Yamazaki et al., 2006). These isoforms have differing affinity for heparin, therefore are either secreted (soluble, VEGF121 and VEGF165) or cell- or matrix-associated (VEGF189, VEGF206, and partially VEGF165). The different isoforms also have differing binding affinity to the VEGF receptors (Gitay-Goren et al., 1992), which results in the diversity of their bioactivities (Yamazaki et al., 2006).
Since VEGF has a fundamental role in angiogenesis, the response to hypoxia and its effects on vasodilation, we hypothesize that VEGF may have a different expression pattern in the plateau pika. In this study, we cloned cDNAs for the VEGF165 and VEGF189 isoforms from pika, and determined their expression patterns in the plateau pika. Our results show that VEGF165 and VEGF189 display tissue and altitude-specific expression patterns in this animal.
Materials and Methods
Animal tissue preparation
Plateau pikas were captured near the Haibei Alpine Meadow Research Station, Chinese Academy of Sciences (altitude 3200 m) and Hoh Xil region near Kunlun Mountain (altitude 4750 m) where vegetation type is alpine meadow in Qinghai province, China. The annual mean air temperatures at these two sites are −1.7°C and −11.7°C, respectively, for the last decade. Zhou Le et al. found that genetic distance and geographical distance of plateau pika population have no significant correlation (Zhou et al., 2007). Yang et al. (2008) found that altitude has no significant effect on substitution rates of the gene-like leptin in pika. Here ten individuals of plateau pika from each site were used for mRNA analysis. Animals were killed by cervical dislocation and immediately dissected at collection. Heart, lung, liver, spleen, kidney, brain, and muscle tissues were rapidly removed and frozen in liquid nitrogen. All procedures involving the handling and care of animals were in accordance with China's Practice for the Care and Use of Laboratory Animals and were approved by the Chinese Zoological Society.
RNA and cDNA preparation
Total RNA was extracted and purified from heart, lung, liver, spleen, kidney, brain, and muscle tissues of the plateau pika using TRIZOL reagent (Invitrogen, Carlsbad, CA, USA). RNA samples were then treated with RNase-free DNase I (TaKaRa Biotechnology Co. Ltd., Dalian, China), and the concentration was determined with an Ultrospec 3000. RNA integrity was tested by electrophoresis through a formaldehyde-denaturing 1% agarose gel. Four micrograms of total RNA treated with DNase I were used for first-strand cDNA synthesis using the RevertAid™ H Minus First Strand cDNA Synthesis kit (MBI, Fermantase, Opelstr., Germany) with oligo(dT)18 primers in a final volume of 20 μL. Once synthesized, cDNA samples were diluted 20-fold with nuclease-free water and used for standard PCR or real-time PCR reactions.
Cloning
Primers were designed based on the full-length coding sequence (CDS) of human, mouse, and Norway rat VEGF165/164. Primers are shown in Figure 2. Using plateau pika brain and muscle cDNA as templates, amplification was carried out with an initial denaturation at 94°C for 5 min, followed by 30 cycles of 94°C for 40 sec, 52°C for 30 sec and 72°C for 1 min, and a final extension at 72°C for 10 min. Amplified DNA fragments were subcloned into the pGEM-T Easy Vector (Promega, Madison, WI, USA) and sequenced.

PCR primers used for RT-PCR and real-time RT-PCR.
Sequence analysis
The CDS of plateau pika VEGF was translated to obtain the protein sequence using BioEdit software. Multiple sequence alignments were performed with the deduced VEGF165/164 and VEGF189/188 protein sequences of Ochotona curzoniae, Homo sapiens (VEGF165, AAA35789; VEGF189, CAC19513), Oryctolagus cuniculus (Watkins et al., 1999), Rattus norvegicus (VEGF164, AAL07526; VEGF188, AAL07528), and Mus musculus (VEGF164, NP_033531; VEGF188, NP_001020421) using CLUSTAL X 1.81 (Thompson et al., 1994). Phylogenetic trees were constructed from the amino acid sequences of VEGF165/164 and VEGF189/188 of plateau pika and other species using the neighbor-joining method with MEGA version 4.0 (Tamura et al., 2007).
RT-PCR analysis
Expression of total VEGF, VEGF165, and VEGF189 mRNAs were determined in pika heart, lung, liver, spleen, kidney, brain, and muscle by a one-step RT-PCR method. Aliquots of total RNA were reverse-transcribed at 50°C for 30 min. The primers (sense, 5′TTGCTGCTCTACCTCCAC3′; antisense, 5′ATGTCCACCAAGGTCTCG3′) for the amplification of total VEGF were designed in the common coding regions (nucleotides 1–422) of all VEGF isoforms. One pair of primers was designed to determine both VEGF165 and VEGF189. PCR products from this pair of primers have different sizes and can be separated on gel electrophoresis. These primers are shown in Figure1.
Real-time PCR analysis
PCR amplification was performed by using SYBR GreenER™ qPCR Supermix (Invitrogen) in a final reaction volume of 20 μL. Each reaction contained 0.8 μL of diluted cDNA samples or plasmid along with 200 nM primers. For standard curves, dilutions of plasmid-DNA constructs containing the amplicons of each gene were used. The PCR plate was incubated at 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec and 60°C for 1 min. Absolute gene quantification was carried out using the ABI PRISM 7000 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). Samples were isolated from individual animals, and each sample was tested in triplicate. Normalization was done by dividing the average expression measurement of each gene by that of β-actin in each sample.
In order to specifically amplify pika VEGF165 or VEGF189, reverse primers specific to each sequence were designed, which also do not allow genomic DNA to be amplified. All primers are shown in Figure 2.
Data analysis
Statistical analyses were performed using SPSS 13.0 software. A student's t-test was used to evaluate the significance of differences between groups of experiments. All values were expressed as mean±S.D. and P<0.05 was considered to be statistically significant.
Results
Cloning and characterization of VEGF cDNAs in the plateau pika
We cloned two VEGF isoforms from the brain and muscle of plateau pika with full-length CDS of 576 bp and 648 bp. These two isoforms of pika VEGF were predicted to contain 191 and 215 amino acids, both with an apparent signal peptide (26 amino acids). The nucleotide sequences and the predicted amino acid sequences are presented in Figure 3 and were deposited in GenBank (cDNA: EU262733 and EU262734; protein: ACA23169 and ACA23170, respectively). The mature secreted proteins are predicted to be 165 and 189 amino acids in length; therefore we named the two isoforms pVEGF165 and pVEGF189, respectively. The molecular weights (MW) of the two isoforms were calculated to be 19.43 KDa and 22.32 KDa and have isoelectric points (pI) of 7.93 and 9.27. The pika VEGFs were predicted to have one N-glycosylation site, one N-myristoylation site, one casein kinase II phosphorylation site, five protein kinase C phosphorylation sites, and one cAMP- and cGMP-dependent protein kinase phosphorylation site. In addition, there is one bipartite nuclear localization signal profile in VEGF189.

Plateau pika VEGF cDNA and deduced amino acid sequence. The sequence represents the combined sequence of two cDNA derived from pika VEGF165 and VEGF189. Predicted motifs and the signal peptide sequence are shaded with a gray background with abbreviated names under them. The blue font indicates a bipartite nuclear localization signal profile (NLS_BP) in VEGF189. The part of the cDNA (72bp) and amino acid sequence (24aa) missing in VEGF165 is boxed. Oligonucleotide primers used to generate the clones are underlined. The abbreviation for the motifs are: CK-2, casein kinase II phosphorylation site; N-glycosylation, N-glycosylation site; N-myristoylation, N-myristoylation site; PKC, protein kinase C phosphorylation site; CAMP, cAMP- and cGMP-dependent protein kinase phosphorylation site.
Analysis of the amino acid sequence reveals that the pika VEGF165 shares 94, 96, 90, 90, 95, 96, 75, and 76% of identity to orthologs in human, rabbit, mouse, Norway rat, bovine, dog, chicken, and African clawed frog. The amino acid sequence identity of pika VEGF189 to orthologs in human, rabbit, mouse, Norway rat, dog, and chicken is also high (94, 96, 90, 90, 95, and 76%, respectively). Cysteine residues, which can form disulfide bonds, at positions 26, 51, 57, 60, 61, 68, 102, and 104 of the receptor-binding domain; and 141, 144, 159, 161, 163, 170, 182, and 184 in the heparin-binding domain of pika VEGF165 and VEGF189 are highly conserved among species (Fig. 4).

Multiple alignment of the amino acid sequence of plateau pika VEGF165/189 with those from human (Homo sapiens), rabbit (Oryctolagus cuniculus), Norway rat (Rattus norvegicus), and mouse (Mus musculus). Identical amino acids are shaded with a gray background. The receptor-binding domain and heparin-binding domain are boxed. Conserved cystein residues are indicated by the asterisks.
Phylogenetic trees were constructed based on the VEGF165 and VEGF189 sequences of plateau pika and the other vertebrates, respectively. The results indicate that both VEGF165 and VEGF189 from pika are most closely related to those from the rabbit (Fig. 5A and B). These phylogenetic trees are in accordance with those obtained from hemoglobin (Yingzhong et al., 2007), HIF-1α, and Cytb (not published).

Phylogenetic relationships of the plateau pika and other species VEGF165/164
Pika and human VEGF165 and VEGF189 show some differences, although they are highly conserved. Differences occur in the receptor-binding domain for both VEGF165 and VEGF189 (Glu6Gly, Asp8Gly, His9Gln, Lys10Asn, Pro11His, Arg22Gln, Arg27His, Ala58Gly, Ser65Gly, and Phe74Ser in mature protein) as well as a change in Ala139Val, next to the heparin-binding domain of VEGF189 (Fig. 6).

Comparison of the amino acid sequences of VEGF165 and VEGF189 between plateau pika and human. Differences between the sequences are shown in the white region. A receptor-binding domain and a heparin-binding domain are boxed.
Expression of total VEGF in plateau pika
Total VEGF mRNA was expressed in a tissue-specific mode in the plateau pika. The mRNA levels of VEGF were the highest in lungs, and the levels were higher in hearts, livers, kidneys, and muscles than in spleens and brains. This expression pattern in the pika is similar with that in mouse living at sea level (data not shown).
Expression patterns of plateau pika VEGF165 and VEGF189
To study the expression patterns of pika VEGF165 and VEGF189, RT-PCR was performed using mRNA from different tissues. Results demonstrate that VEGF165 and VEGF189 were widely expressed in the pika (heart, lung, liver, spleen, kidney, brain, and muscle), but the relative amounts of VEGF165 and VEGF189 mRNAs varied among tissues (Fig. 7A). To determine the relative levels of VEGF165 and VEGF189 mRNA accurately, a real-time RT-PCR analysis was performed. The results of this analysis showed that the expression of the two isoforms was quite distinct in the different tissues of the pika. VEGF189 was most highly expressed in the lung, but also highly abundant in the heart. The expression of VEGF165 was not as high as VEGF189 in the lung and heart and showed similar levels in the heart, lung, liver, and kidney. The relative expression levels of VEGF165 and VEGF189 mRNA showed some interesting patterns: VEGF189 was the dominant isoform in the heart, lung, and muscle tissues, while both were roughly equally abundant in liver and kidney tissues and both were expressed weakly in the spleen and brain tissues (Fig. 7B). Despite low expression, the level of VEGF189 is higher than that of VEGF165 in the brain.

Expression of total VEGF,VEGF165 and VEGF189 mRNA in different plateau pika tissues.
Expression of VEGFs in plateau pika in relation to habitat altitude
Since VEGF plays an important role in the tissue response to hypoxia, we questioned whether the expression of VEGF165 and VEGF189 would be different in the pikas inhabiting different altitudes. To resolve this question, we determined the mRNA levels of VEGF165 and VEGF189 in the brain, muscle, and lung tissues of pikas inhabiting altitudes of 3200 and 4750 m. Then VEGF165 and VEGF189 mRNA levels were normalized by β-actin since β-actin, as a housekeeping gene, has no significant difference between these two groups (Li et al., 2009).The data show that VEGF165 and VEGF189 mRNA levels were significantly increased in the brains of the animals inhabiting the altitude of 4700 m, compared with those at 3200 m (p<0.01 and p<0.01, respectively). The levels of VEGF189 appear to be increased more than those of VEGF165 (Fig. 8A). In the muscle (Fig. 8B) and lung (Fig. 8C), VEGF189 levels were also significantly increased in the animals inhabiting an altitude of 4750 m compared to those at 3200 m (p<0.01 and p<0.001, respectively), while VEGF165 shows no significant difference. These data indicated that VEGF189 mRNA levels are increased in the animals that inhabit higher altitudes.

Comparison of VEGF165 and VEGF189 mRNA levels in plateau pikas inhabiting different altitudes. mRNA expression levels of VEGF165 and VEGF189 in brain
Discussion
To adapt to a high-altitude environment, plateau animals have developed unique characteristics. The plateau pika, as a typical plateau mammal, has been extensively studied to understand this adaptation. HIF-1α (Li et al., 2008, Zhao et al., 2004) and leptin (Yang et al., 2006) expression, and leptin (Yang et al., 2008) and Hb (Yingzhong et al., 2007) amino acid substitutions have been linked to adaptation in the pika. Here we present for the first time the isolation and characterization of VEGF, another gene that is sensitive to the environment, from the plateau animal. The novel expression pattern of VEGF165 and VEGF189 may be involved in adaptation of the pika since phylogenetic analysis reveals the conservation of pika VEGF165 and VEGF189.
Several studies have shown that VEGF165/164 and VEGF189/188 isoforms mRNA display tissue-specific expression. VEGF188 is the most abundant isoform in lung and heart, whereas VEGF164 is more highly expressed in murine muscle, brain, liver, spleen, and kidney (Bacic et al., 1995, Ng et al., 2001). Watkins et al. (1999) reported that VEGF189 is most highly expressed in rabbit lung, whereas VEGF165 is most abundant in liver, spleen, and kidney. The predominance of VEGF188 in heart and lung distinguishes these two tissues from all others examined. This suggests that VEGF189/188 may play a specific or exclusive role in cardiopulmonary function. It has been demonstrated that VEGF188 produced by the rat pulmonary epithelium mediates the assembly and stabilization of the highly organized vessel network that surrounds the alveoli (Ng et al., 2001).
In our study, RT-PCR and real time RT-PCR-based expression analysis revealed that VEGF189 mRNA expression was significantly higher than VEGF165 in the plateau pika brain and muscle. This is a novel finding because earlier studies had shown that VEGF165 mRNA expression is higher than VEGF189 in the brain and muscle of mice and rat, animals found at sea level (Bacic et al., 1995, Ng et al., 2001). The recent study (Zheng et al., 2011) found that the microvessel density is significantly increased in the pika brain compared with sea-level rat brain (602.1±66.98 vs. 426.75±58.25 microvessels per mm2). Therefore, higher-level VEGF189 may be required for more microvessels in pika brain to adapt to hypoxia since VEGF189 was reported to have the capability to induce the most-dense, small, sprouting microvessels (Yuan et al., 2011). However, there is a lower microvessel density but higher Mb (myoglobin) in the pika skeletal muscle compared to sea-level rat muscle (microvessel density: 603.70±115.88 vs. 1009.63±138.48 microvessels per mm2; Mb: 0.91±0.09 vs. −0.08±0.49 logCMb/logCGAPDH). Yan, et al.(2009) found the muscle-specific Mb overexpressing transgenic mice had a lower vascular density, although it, at VEGF level, has similar response to ischemia injury with wild-type mouse. VEGF overexpression has been reported to increase the Mb expression rather than angiographic score of collateral arteries in the mouse muscle (van Weel et al., 2004). Therefore, the higher-level VEGF189 in the pika muscle may be involved in its adaptation to high altitude hypoxia through increasing Mb expression since Mb has higher affinity to O2.
Changes in the ratio of VEGF isoforms have been demonstrated to be related to responses to systemic hypoxia (Hofstaetter et al., 2004) or glucose starvation (Zhang et al., 2002). Systemic hypoxia has been shown to differentially affect expression of VEGF isoform mRNA (Marti et al., 1998, Watkins et al., 1999). Birot et al. (2004) have reported that VEGF188 levels are transiently elevated in the rat heart in response to systemic hypoxia, whereas no change was found in VEGF164 mRNA levels. Transient elevation of VEGF has been demonstrated to occur at the time of initial adaptation in the mouse brain in response to chronic hypoxia (Kuo et al., 1999). Hypoxia is well known to be a major feature of the plateau environment. In this study, we found that VEGF189 mRNA levels remain higher in the brain and muscle of native pika inhabiting higher altitudes. This may account for the higher abundance of VEGF189 compared with VEGF165 in the pika brain and muscle. It should be noted that the increase is permanent, not transient. This suggests that pika may need to retain relatively higher levels of VEGF189 than VEGF165 expression in the brain and muscle in order to adapt to the higher-altitude environments, as changes in VEGF165 expression were less than those for VEGF189 levels between pikas inhabiting different altitudes.
The two sites in the present study have an extremely cold and hypoxic plateau climate. The most obvious differences between these two sites are altitude and ambient temperature. The altitudes of the two sites are 3200 m and 4750 m, with average temperatures of −1.7°C and −11.7°C, respectively. As altitude increases and temperature decreases, the partial pressure of oxygen decreases. Thus the partial pressure of O2 (P
In summary, we have cloned VEGF165 and VEGF189 isoforms from the plateau pika, and found that they were expressed in a tissue-specific manner. Specifically, VEGE189 has a higher expression than VEGF165 in pika brain and muscle, which may be involved in pika brain's and muscle's adaptation to hypoxia through different mechanisms. Further, VEGE189 levels in pika brain, muscle, and lung are correlated to the altitudes of their habitat. All these changes could allow the animal to adapt to the hypoxia challenges of its natural habitat.
Footnotes
Acknowledgments
We thank Dr. David M. Irwin (University of Toronto) for reading and revising our manuscript, and Dr. Tong Sun and Dr. Yan-Jie Li for their help in the real-time PCR experiment
Author Disclosure Statement
The authors declare no conflicting financial interests.
This work was greatly supported by a grant from The Knowledge Innovation project of the Chinese Academy of Sciences (0254051211).
